Influence of ADP on cross-bridge-dependent activation of myofibrillar thin filaments.
Contraction of skeletal muscle is regulated by calcium at the level of the thin filament via troponin and tropomyosin. Studies have indicated that strong cross-bridge binding is also involved in activation of the thin filament. To further test this, myofibrils were incubated with a wide range of fluorescent myosin subfragment 1(fS1) at pCa 9 or pCa 4 with or without ADP. Sarcomere fluorescence intensity and the fluorescence intensity ratio (non-overlap region/overlap region) were measured to determine the amount and location of bound fS1 in the myofibril. There was lower sarcomere fluorescence intensity with ADP compared to without ADP for both calcium levels. Similar data were obtained from biochemical measures of bound fS1, validating the fluorescence microscopy measurements. The intensity ratio, which is related to activation of the thin filament, increased with increasing [fS1] with or without ADP. At pCa 9, the fluorescence intensity ratio was constant until 80-160 nM fS1 without ADP conditions, then it went up dramatically and finally attained saturation. The dramatic shift of the ratio demonstrated the cooperative character of strong cross-bridge binding, and this was not observed at high calcium. A similar pattern was observed with ADP in that the ratio was right-shifted with respect to total [fS1]. Saturation was obtained with both the fluorescence intensity and ratio data. Plots of intensity ratio as a function of normalized sarcomere intensity (bound fS1) showed little difference between with and without ADP. This suggests that the amount of strongly bound fS1, not fS1 state (with or without ADP) is related to activation of the thin filament.
Zhang
D
D
Department of Anatomy and Cell Biology, Indiana University Medical School, Indianapolis 46202, USA.
Yancey
K W
KW
Swartz
D R
DR
D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002417:Cattle; D007700:Kinetics; D009119:Muscle Contraction; D018482:Muscle, Skeletal / Q000502:physiology*; D009210:Myofibrils / Q000187:drug effects / Q000502:physiology*; D015879:Myosin Subfragments / Q000737:chemistry* / Q000187:drug effects / Q000378:metabolism*; D011817:Rabbits; D012518:Sarcomeres / Q000187:drug effects / Q000502:physiology*
D015879:Myosin Subfragments; D000244:Adenosine Diphosphate; D002118:Calcium